About SeaBeLife
SeaBeLife is a biotechnology company developing two families of patented candidate molecules designed to block regulated necrosis – also known as regulated cell death.
Our therapeutic solution has demonstrated, in vitro and in multiple in vivo proofs-of-concept, to be able to simultaneously block two forms of regulated cell death and thus protect organs under attack from disease.
Advertisement
Here you will find SeaBeLife
Last viewed contents
Bacteria ‘pills’ could detect gut diseases — without the endoscope - “This technology provides a new paradigm for rapid and non-invasive detection of gastrointestinal diseases”
Capricorn Scientific and florabio Join Forces to Revolutionize Animal-Free, High-Yield Cell Culture Media
DiagnostikNet-BB e.V. - Stadt Hennigsdorf, Germany
Biotage AB appointment of new CEO
BIO CITY LEIPZIG - Leipzig, Germany
GEA Supervisory Board takes early decision to extend contract of CEO Stefan Klebert - Company resolves to restructure the Executive Board and streamline the organizational structure as of January 1, 2026
